lomustine has been researched along with Minimal Disease, Residual in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Six patients (21%) had residual cancer in the resected specimen, either at the primary site or--more often--in adjacent lymph nodes." | 2.68 | Treating esophageal cancer with a combination of chemotherapy, radiation, and excision. ( Bates, DM; Clyde, JC; Garcia, JM; Girvin, GW; Lin, PH; Matsumoto, GH, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobiakov, GL | 1 |
| Girvin, GW | 1 |
| Matsumoto, GH | 1 |
| Bates, DM | 1 |
| Garcia, JM | 1 |
| Clyde, JC | 1 |
| Lin, PH | 1 |
| Jakacki, RI | 1 |
| Zeltzer, PM | 1 |
| Boyett, JM | 1 |
| Albright, AL | 1 |
| Allen, JC | 1 |
| Geyer, JR | 1 |
| Rorke, LB | 1 |
| Stanley, P | 1 |
| Stevens, KR | 1 |
| Wisoff, J | 1 |
| Packer, RJ | 1 |
| Sutton, LN | 1 |
| Elterman, R | 1 |
| Lange, B | 1 |
| Goldwein, J | 1 |
| Nicholson, HS | 1 |
| Mulne, L | 1 |
| Boyett, J | 1 |
| D'Angio, G | 1 |
| Wechsler-Jentzsch, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An International, Randomized, Open-label Phase I/II Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Adult Patients With Recurrent or Refractory Medulloblastomas Presenting an Activation of the Sonic Hedgehog (SHH) Pathway[NCT01601184] | Phase 1/Phase 2 | 24 participants (Actual) | Interventional | 2012-06-30 | Terminated (stopped due to The number of successes is not reached at the end of first stage of the phase II. The study is stopped.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for lomustine and Minimal Disease, Residual
| Article | Year |
|---|---|
[Clinical significance of mustoforan in management of malignant glioma].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Astrocytoma; Blood-Brain Barr | 2007 |
3 trials available for lomustine and Minimal Disease, Residual
| Article | Year |
|---|---|
Treating esophageal cancer with a combination of chemotherapy, radiation, and excision.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel | 1995 |
Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Childrens Cancer Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Pr | 1995 |
Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherap | 1994 |